[生物制剂] - Suppr | 超能文献

[Biologics].

作者信息

Kalden J R

机构信息

Abteilung für Molekulare Immunologie, Friedrich-Alexander Universität Erlangen-Nürnberg, Nikolaus-Fiebiger-Zentrum, Glückstr. 6, 91054, Erlangen, Deutschland.

出版信息

Z Rheumatol. 2016 Aug;75(6):604-10. doi: 10.1007/s00393-016-0122-2.

DOI:10.1007/s00393-016-0122-2

PMID:27365024

Abstract

摘要

相似文献

[Biologics].

Z Rheumatol. 2016 Aug;75(6):604-10. doi: 10.1007/s00393-016-0122-2.

[Coxibs].

Z Rheumatol. 2016 Aug;75(6):595-8. doi: 10.1007/s00393-016-0148-5.

Possible discontinuation of therapies in inflammatory rheumatic diseases - as with initiation of therapies, a shared decision between patient and rheumatologist.

Clin Exp Rheumatol. 2013 Jul-Aug;31(4 Suppl 78):S1-3. Epub 2013 Oct 3.

[Update on kinase inhibitors].

Z Rheumatol. 2016 Aug;75(6):611-5. doi: 10.1007/s00393-016-0113-3.

Upcoming biologic agents for the treatment of rheumatic diseases.

Curr Opin Rheumatol. 2003 May;15(3):226-36. doi: 10.1097/00002281-200305000-00009.

Reduction or cessation of antiviral agents in hepatitis B virus carriers treated with biologic agents.

Clin Exp Rheumatol. 2018 Jan-Feb;36(1):170. Epub 2018 Jan 15.

[Glucocorticoids].

Z Rheumatol. 2016 Aug;75(6):591-4. doi: 10.1007/s00393-016-0115-1.

BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids.

Rheumatology (Oxford). 2016 Sep;55(9):1693-7. doi: 10.1093/rheumatology/kev404. Epub 2016 Jan 10.

[Treatment of cardiovascular risk factors].

Z Rheumatol. 2016 Mar;75(2):173-80; quiz 181-2. doi: 10.1007/s00393-016-0064-8.

[Methotrexate].

Z Rheumatol. 2016 Aug;75(6):599-603. doi: 10.1007/s00393-016-0118-y.

本文引用的文献

Anti-Drug Antibodies, Drug Levels, Interleukin-6 and Soluble TNF Receptors in Rheumatoid Arthritis Patients during the First 6 Months of Treatment with Adalimumab or Infliximab: A Descriptive Cohort Study.

PLoS One. 2016 Sep 8;11(9):e0162316. doi: 10.1371/journal.pone.0162316. eCollection 2016.

Efficacy and safety of ustekinumab in psoriatic arthritis patients with peripheral arthritis and physician-reported spondylitis: post-hoc analyses from two phase III, multicentre, double-blind, placebo-controlled studies (PSUMMIT-1/PSUMMIT-2).

Ann Rheum Dis. 2016 Nov;75(11):1984-1988. doi: 10.1136/annrheumdis-2015-209068. Epub 2016 Apr 20.

Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis.

N Engl J Med. 2015 Dec 24;373(26):2534-48. doi: 10.1056/NEJMoa1505066.

Discovery and characterization of COVA322, a clinical-stage bispecific TNF/IL-17A inhibitor for the treatment of inflammatory diseases.

MAbs. 2016;8(1):141-9. doi: 10.1080/19420862.2015.1093266. Epub 2015 Sep 22.

Z Rheumatol. 2015 Oct;74(8):682-8. doi: 10.1007/s00393-014-1487-8.

Z Rheumatol. 2015 Oct;74(8):672-81. doi: 10.1007/s00393-014-1486-9.

Effectiveness and survival-on-drug of certolizumab pegol in rheumatoid arthritis in clinical practice: results from the national Swedish register.

Scand J Rheumatol. 2015;44(6):431-7. doi: 10.3109/03009742.2015.1026840. Epub 2015 Jun 18.

Efficacy and safety of tabalumab, an anti-B-cell-activating factor monoclonal antibody, in patients with rheumatoid arthritis who had an inadequate response to methotrexate therapy: results from a phase III multicentre, randomised, double-blind study.

Ann Rheum Dis. 2015 Aug;74(8):1567-70. doi: 10.1136/annrheumdis-2014-207090. Epub 2015 Apr 14.

Correction to Lancet Oncol 2015; 16: 60, 61. Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multi-centre, single-arm, phase 2 study.

Lancet Oncol. 2015 Apr;16(4):e158. doi: 10.1016/S1470-2045(15)70154-3.

[Pathogenic cells of rheumatic inflammation as the target of modern therapies].

Z Rheumatol. 2015 Feb;74(1):8-13. doi: 10.1007/s00393-014-1437-5.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

[Biologics].

作者信息

机构信息

出版信息

相似文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

本文引用的文献